Results

Total Results: 1,211 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

141. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/psoriasis-chronic/research-protocol
     December 01, 2019 - the main research gaps identified in this meta-analysis was the lack of comparative effectiveness and safety … Question 2 In patients with chronic plaque psoriasis, what is the comparative safety of systemic biologic … followup), patient baseline characteristics (including whether the patient is naïve to biologic therapy … Since differences in efficacy or safety may exist between agents within a given class (e.g., two biologic … We will also conduct subgroup analyses based on the patient population evaluated, including patients

142. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - A disadvantage of this over individual patient randomization is that outcomes for patients from a … A disadvantage of this over individual patient randomization is that outcomes for patients from a … post-ASCR EFS 1 patient died of toxicity at 3 months follow up. 5 patients were DOD at 5- 21 months … (70%), partial remission in 1 patient (2%) and stable disease in 13 patients (28%). … with high-risk solid tumors Safety/Efficacy study 30 patients (up to 30 years of age) 6/2006

143. Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - This, in turn, may affect the perceived effectiveness or safety of the product if the registry does … Drug Safety. 2015 January 1;38(1):13-5. 4. Elger B, Biller-Andorno N, Mauron A, et al. … http://www.fda.gov/downloads/Drugs/Drug Safety/ucm089809.pdf. Accessed January 10, 2017. 21. … Direct-to-patient research: piloting a new approach to understanding drug safety during pregnancy. … Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private

144. Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
     February 01, 2012 - • Patient insight into illness? … Web-based prioritization exercises allowed each stakeholder to distribute a limited number of star-shaped indicators … some safety outcomes tend to be more homogenous across studies (e.g., weight gain). … Patient registries with linkages of patient-reported outcomes to clinical datasets (such as claims or … Challenge that patients tend to be reluctant to accept randomization.

145. Making Healthcare Safer IV: High Reliability Organization (HRO) as a Patient Safety Practice (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hro-protocol.pdf
     January 01, 2023 - stakeholders, clinical specialists, experts in patient safety issues, and a patient/consumer perspective … groups 6 Study Parameter Inclusion criteria Exclusion criteria • Patients receiving care … /products/prioritization-patient-safety-practices https://effectivehealthcare.ahrq.gov/products/prioritization-patient-safety-practices … The TEP included 15 experts in patient safety with representa... … To accomplish that task, we will review AHRQ’s Patient Safety Networ...

146. Comparative Effectiveness and Safety of Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/insulin-blood-sugar-2010/research-protocol
     December 01, 2019 - SHARE: Comparative Effectiveness and Safety … However, the relative contribution of each of these factors to the disease course varies by patient. … rt-CGM differs from retrospective CGM in that it provides blood glucose feedback data to the patient … In addition, several other factors appear to be especially relevant, including the age of the patient … Internet Citation: Research Protocol: Comparative Effectiveness and Safety

147. Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment–An Update to the 2006 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-anemia-update/research-protocol
     December 01, 2019 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials treated with epoetin alfa … Study and Independent Patient Level Meta-Analysis Selection: Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data … Meta-analyses of safety data: a comparison of exact versus asymptotic methods.

148. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … , 10 diagnostic groups for hospital discharges, 10 diagnostic groups for outpatient visits, and 10 indicators … A common question in pharmacoepidemiologic studies of drug safety is whether the risk conferred by a … Pharmacoepidemiology and Drug Safety 2008;17:546-555. … Pharmacoepidemiol Drug Safety 2005;14(7):465-76.

149. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - for calibrating the CGM (as applicable) and checking sensor performance as needed plus associated reagents … Patients and their diabetes care teams work to adjust patient insulin dosages using feedback from a … health outcomes, citing safety concerns and limited efficacy data. … Summary of safety and effectiveness data (SSED). MiniMed 530G system. P120010. … Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients

150. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
     April 06, 2010 - Timing We will include studies if patients have been on the medications for at least 3 months. … control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients … Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis … Inclusion and exclusion criteria Population and condition of interest □ All studies included patients … We excluded studies that evaluated only patients with type I diabetes, impaired glucose tolerance, metabolic

151. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Treatments are aimed at symptomatic relief, but questions of safety and efficacy remain. … However, other experts thought the availability of a new IBS therapy with a seemingly good safety profile … Salix's TARGET 3 study examines the safety and efficacy of repeat treatment with rifaximin 550 mg … -550 http://news.salix.com/press-release/salixs-target-3-study-examines-safety-and-efficacy-repeat-treatment-rifaximin … -550 http://news.salix.com/press-release/salixs-target-3-study-examines-safety-and-efficacy-repeat-treatment-rifaximin

152. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
     September 01, 2010 - Over time, 73% of patients will have a relapsing and remitting course, while only 10% of patients will … Our proposal will address these aims, as well as the safety and patient-reported outcomes representing … We aim to compare the effectiveness, safety and patient-reported outcomes representing quality of life … The patient-reported outcomes will also help patients and caregivers to take into consideration the … Objectives We aim to compare the effectiveness, safety and patient-reported measures of individual

153. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
     March 13, 2012 - The FDA addresses the safety and effectiveness of diagnostic tests and the quality of the design and … Historically, the FDA has subjected test kits to premarket review of safety and effectiveness but not … Clinical utility should reflect patient outcomes such as improved survival. … result from both preanalytic factors [e.g., sample preparation] as well as analytic factors [such as reagents … Patient advocacy Web sites for colon cancer will be searched.

154. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
     January 10, 2012 - To date, no comparative effectiveness review comparing the effectiveness and safety of FDA-approved … with chronic plaque psoriasis, what is the comparative safety of systemic biologic agents and systemic … followup), patient baseline characteristics (including whether the patient is naïve to biologic therapy … We will also conduct subgroup analyses based on the patient population evaluated, including patients … Efficacy and safety results from the randomized controlled comparative study of adalimumab vs.

155. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
     October 01, 2011 - We also included studies that report safety in patients with rheumatoid arthritis or who were taking … ), diclofenac (10/100 patient-years), and ibuprofen (11/100 patient-years). … disease prevention, usually at lower prophylactic doses GI harms: A systematic review of individual patient … though diclofenac was associated with the highest rate of hepatic laboratory abnormalities (78/1000 patient … - years, vs. 16 to 28/1000 patient-years for the other NSAIDs).

156. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Summary of available data on patient characteristics and response to prior medical treatment have been … outcomes noted in question 1 include healing of erosive esophagitis (EE), ambulatory pH, and other indicators … Commentator & Affiliation Section Comment Response AstraZeneca esophagitis (EE), ambulatory pH, other indicators … comprising 11% of patients in the trials.1 No overall differences were seen in the safety or effectiveness … The safety of Thank you for your comments.

157. Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
     November 01, 2017 - arrest, function, quality of life, other clinical sequelae of opioid overdose; health care utilization indicators … National Highway Traffic Safety Administration. The national EMS scope of practice model. … Joint meeting of the anesthetic and analgesic drug products and the drug safety and risk management … Joint meeting of anesthetic and analgesic drug products advisory committee and drug safety and risk … Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular

158. Efficacy and Safety of Screening for Postpartum Depression | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/depression-postpartum-screening/research-protocol
     December 01, 2019 - Home Evidence Reports Efficacy and Safety … SHARE: Efficacy and Safety … There is high-quality evidence for effective treatment of patients who meet criteria for major depression … Project Timeline Efficacy and Safety of Screening for Postpartum Depression Nov 8, 2011 … 2017 Internet Citation: Research Protocol: Efficacy and Safety

159. Key Questions 1. Does routine preoperative testing compared to no testing or alternative testing strategies improve outcomes (such as surgical complications, other morbidity, and mortality) among patients undergoing elective surgery? 2.… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surg
     November 01, 2017 - tests change patient management decisions? … What patients or group(s) of patients does your question apply to? … safety,1 eliminate delays,15 limit harm from unnecessary follow-up of abnormal tests,7,14 improve system … safety,1 eliminate delays,15 limit harm from unnecessary follow-up of abnormal tests,7,14 improve system … This topic impacts all pre-surgical patients.

160. Outcomes Associated With Tiotropium use in Chronic Obstructive Pulmonary Disease Patients | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/copd-anticholinergic-medicines/research
     January 01, 2020 - Therefore, each patient was given a 30 day immortal period following the switch. … homogeneous patient population. … Thus, there is still need to evaluate tiotropium safety in patient populations who are treatment naïve … Methodologic challenges to studying patient safety and comparative effectiveness. … Methodologic challenges to studying patient safety and comparative effectiveness.